Related Experiment Video

Updated: Jan 6, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and

A Lyon1, A Mincholé2, A Bueno-Orovio2

  • 1Department of Computer Science, University of Oxford, Oxford, United Kingdom; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands.

Morphologie : Bulletin De L'Association Des Anatomistes
|October 2, 2019
PubMed

Insights

Computational techniques identified four hypertrophic cardiomyopathy (HCM) phenotypes with varying arrhythmic risk. This improves patient stratification and understanding of HCM mechanisms for tailored treatment.

Area of Science:

  • Cardiology
  • Computational Biology
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac disease.
  • While many patients remain asymptomatic, some face risks of sudden cardiac death.
  • Accurate risk identification and understanding arrhythmia mechanisms are critical challenges in HCM management.

Purpose of the Study:

  • To implement computational techniques for clinically relevant applications in HCM.
  • To improve patient stratification and understanding of disease mechanisms.
  • To pave the way for tailored patient management and treatment strategies.

Main Methods:

  • Integration of electrocardiogram (ECG) and imaging data.
  • Application of machine learning algorithms.
  • Utilization of high-performance computing simulations.

Main Results:

  • Identification of four distinct phenotypes in HCM patients.
  • Demonstrated differences in arrhythmic risk among the identified phenotypes.
  • Proposed two distinct mechanisms explaining the heterogeneity of HCM manifestation.

Conclusions:

  • Computational approaches offer a powerful tool for analyzing complex cardiac data.
  • The study successfully stratified HCM patients into risk-based phenotypes.
  • Enhanced understanding of HCM mechanisms facilitates personalized treatment approaches.

Keywords:
Cardiac magnetic resonance imagingComputational clusteringComputer modelingElectrocardiographyHypertrophic cardiomyopathyPersonalized simulationsPhenotypingVPHe-cardiology

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K
Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations12:09

Patient-specific Modeling of the Heart: Estimation of Ventricular Fiber Orientations

Published on: January 8, 2013

14.0K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
465
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427